PMH13 SYSTEMATIC REVIEW OF UTILITY VALUES USED IN THE PHARMACOECONOMIC EVALUATIONS FOR SCHIZOPHRENIA: IMPLICATIONS ON COST-EFFECTIVENESS RESULTS

Abstract

Authors

J. Zhou A. Millier C. François S. Aballea M. Toumi

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×